http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-9306529-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
filingDate 1993-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_786dbb8ab52244665466ef3deefa7572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ecd88aefbc315b024c8828b7695d076
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ffc6a8fa5eb8f488b36b6a64fb09934c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4abf28d6f5de320e2c9daec14c5a964
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70428d23dd561dbbac96a08bc765f63e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ad58205bbd1069bad89dd3ef93229aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8ad419c13c21c29040d90fc8fdd0b45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32f645d2cac2e571ca2b1ab69e8c2c85
publicationDate 1994-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-9306529-A
titleOfInvention DERIVATIVES OF CONDENSED PYRAZOLE, METHOD TO MANUFACTURE THEM AND THE PHARMACEUTICAL COMPOSITION CONTAINING THEM
abstract The invention provides a condensed pyrazole derivative of formula (I); (where A denotes CH or N, R0 and R3 denote the same or different, a hydrogen atom or a lower alkyl group; R1 and R2, are the same or different, and are a hydrogen atom, a lower alkyl group, a lower alkoxy group, an alkylthio group, a nitro group, or a halogen atom, m denotes 1 or 2, and n denotes 1, 2, or 3 provided that, when n is 2, two R 2 can join together to form a lower alkylenedioxy group) or its pharmaceutically acceptable salt. This derivative or its salt is excellent in the effect of inhibiting the expression of androgen action, therefore it is excellent in the therapeutic effect of benign prostatic hypertrophy, prostatic carcinoma, etc., and has a long duration of activity and its high absorption. oral.
priorityDate 1992-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425914843
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722

Total number of triples: 23.